TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | 1 | 14 | 28 | 28 | 78 | 25 |
| P | %wins | 50 | 50 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/17 18:26 | 8/11/17 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Winningham Rick E | CA | DO | CEO | P | 245 | 24.50 | 0 | 10 | 1 | 866 | D | ||||||||||||||
8/17/15 19:21 | 8/14/15 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Winningham Rick E | CA | DO | CEO | P.m | 949 | 11.86 | 2 | 80 | 15 | 602 | D | -57 | -35 | -19 | -5 | 1 | -3 | 0 | 6 | 9 | 11 | 39 | 27 | 133 | |
3/11/08 19:13 | 3/11/08 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Winningham Rick E | CA | DO | CEO | P | 209 | 10.47 | 23 | 20 | 87 | 43 | D | -63 | -67 | -65 | -60 | -49 | -45 | -40 | -19 | -1 | -8 | 17 | 17 | 28 | 22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |